Netzsch removes risk from process scaling

Published: 16-Nov-2010
Manufacturing

LabStar multi-functional mill can be scaled-up to comparable production machines

Netzsch removes risk from process scaling
Netzsch Mastermix, part of Netzsch Group’s grinding and dispersing business unit, has developed the LabStar Pilot/Laboratory bead mill, which is the smallest grinding mill in its portfolio.

The company says the LabStar can be directly scaled up to its larger cousins in the Netzsch bead mill range.

Configurable as a Zeta peg milling system or as a TriNex disc milling system, LabStar replicates all of the possible combinations and applications that are encountered by full-size production mills.

Available in a range of materials, and ATEX certified, the Lichfield, UK-based firm says there is a configuration to match any production situation that needs to be accurately defined at a pilot scale.

  • Companies:
  • Netzsch Group
See more

You may also like

Manufacturing
Fine granulation and greater efficiency

Fine granulation and greater efficiency

Read more
Until recently, achieving fine granulation meant lower productivity. Andy James, at Netzsch Mastermix, argues that with high density bed jet mills this is no longer the case

Trending Articles

  1. From speed to strategy: how UK life sciences should respond to China’s rise A group of biotech founders, big pharma leaders, clinical and CMC specialists, and CDMO executives gathered at a recent dinner sponsored by AsymChem to discuss a question now sitting in many boardrooms: what is China’s maturing biopharma ecosystem doing to the global industry, and how should UK companies respond?
  2. UK liquid manufacturing: why British production matters for healthcare and the economy How specialist liquid manufacturing in Newcastle supports UK healthcare supply chains, skilled employment and pharmaceutical and nutraceutical production
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    UK Budget 2026: what it means for pharma manufacturing VAT relief on free medicines, £1bn in new investment and revised capital allowances give pharma manufacturers progress — but gaps remain
  4. Viewlinc Cloud Suite supports life science innovation from laboratory to regulated operations Cloud-based environmental monitoring helps life science organisations establish professional-quality monitoring from day one and scale as requirements evolve
  5. ESTEVE CDMO invests $80m in new China API manufacturing site The Shaoxing facility will provide 250 m³ of reaction volume, with potential capacity exceeding 400 m³, as the CDMO expands its global small-molecule API manufacturing network

You may also like

Manufacturing
Fine granulation and greater efficiency

Fine granulation and greater efficiency

Until recently, achieving fine granulation meant lower productivity. Andy James, at Netzsch Mastermix, argues that with high density bed jet mills this is no longer the case
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing
Taking biologic therapies out of the clinic

Taking biologic therapies out of the clinic

How larger autoinjectors are changing drug delivery device testing
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing
How intelligent checkweighers offer improved productivity in pharmaceutical manufacturing

How intelligent checkweighers offer improved productivity in pharmaceutical manufacturing

Precise weighing, automated reporting and tailored handling help pharmaceutical producers reduce waste, streamline compliance processes and maintain reliable output across demanding production lines
Manufacturing
Shilpa CDMO invests $50m to expand peptide manufacturing capacity in India

Shilpa CDMO invests $50m to expand peptide manufacturing capacity in India

The CDMO is investing $50m in additional solid-phase peptide synthesis capacity and a new commercial manufacturing line at its Raichur campus, expanding its capabilities to meet demand for GLP-1s and increasingly complex peptide therapeutics across oncology and rare diseases
Manufacturing
Pace Life Sciences completes EMA GMP inspection at New Jersey CDMO facility

Pace Life Sciences completes EMA GMP inspection at New Jersey CDMO facility

The inspection supports renewal of the EU GMP certificate at the company's New Jersey site, which provides pharmaceutical analytical testing, microbiology and development services
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing
UK Budget 2026: what it means for pharma manufacturing

UK Budget 2026: what it means for pharma manufacturing

VAT relief on free medicines, £1bn in new investment and revised capital allowances give pharma manufacturers progress — but gaps remain
Manufacturing
How to remove impurities without wasting solvent using ANFD technology

How to remove impurities without wasting solvent using ANFD technology

Discover how Agitated Nutsche Filter Dryers (ANFDs) optimise API cake washing. Combine re-slurry agitation with in-process monitoring to hit target purity while reducing overall solvent waste
Subscribe now